Nuvectis Pharma (NVCT) Update / Briefing Transcript

Nuvectis Pharma (NVCT) Update / Briefing August 12, 2025 08:30 AM ET Speaker0Greetings, and welcome to the Nuvectis Pharma NXP-nine hundred Phase Ib Study Initiation Conference Call. At this time, all participants are in listen only mode. As a reminder, this conference is being recorded. Joining me on the call today will be Ron Bensour, Co Founder, Chairman, and Chief Executive Officer of Nuvectis Pharma. Also joining us for Q and A are Enrique Prasadu, Co Founder, Executive Vice President, Chief Scientific ...